Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dorota Korycińska-Chaaban"'
Autor:
Dariusz Walkowiak, Jan Domaradzki, Renata Mozrzymas, Dorota Korycińska-Chaaban, Monika Duś-Żuchowska, Bożena Didycz, Bożena Mikołuć, Jarosław Walkowiak
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 36, Iss , Pp 100992- (2023)
Introduction: Clinical management of rare diseases often fails to acknowledge the challenges faced by caregivers. Whilst management of phenylketonuria (PKU) may not be considered as dire as other conditions, most studies primarily concentrate on clin
Externí odkaz:
https://doaj.org/article/fccd3fac0f55439394bee5224ab87a2c
Autor:
Dariusz Walkowiak, Bożena Mikołuć, Renata Mozrzymas, Łukasz Kałużny, Bożena Didycz, Dorota Korycińska-Chaaban, Michał Patalan, Joanna Jagłowska, Agnieszka Chrobot, Rafał Staszewski, Jarosław Walkowiak
Publikováno v:
Children, Vol 9, Iss 2, p 131 (2022)
The first pandemic lockdown dramatically impacted many aspects of everyday life, including healthcare systems. The purpose of this study was to identify problems of patients with phenylketonuria (PKU) and their parents/caregivers during that time. We
Externí odkaz:
https://doaj.org/article/35fe2e78352a4775a41059a4beac025f
Autor:
Dariusz Walkowiak, Bożena Mikołuć, Renata Mozrzymas, Łukasz Kałużny, Bożena Didycz, Dorota Korycińska-Chaaban, Michał Patalan, Joanna Jagłowska, Agnieszka Chrobot, Rafał Staszewski, Jarosław Walkowiak
Publikováno v:
Children; Volume 9; Issue 2; Pages: 131
The first pandemic lockdown dramatically impacted many aspects of everyday life, including healthcare systems. The purpose of this study was to identify problems of patients with phenylketonuria (PKU) and their parents/caregivers during that time. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a952c2e8577476f476b66874ca23131
https://pubmed.ncbi.nlm.nih.gov/35204852
https://pubmed.ncbi.nlm.nih.gov/35204852
Autor:
Artur Kościesza, Dorota Korycińska-Chaaban, Edyta Ciecieląg, Maria Nowacka, Elzbieta Szponar, Kamil K. Hozyasz
Publikováno v:
Pediatria Polska. 89:297-301
Phenylketonuria (PKU) is an autosomal recessive metabolic disease caused by an error of phenylalanine metabolism. Delayed treatment or treatment performed unsystematically might lead to neurological disorders and progressive intellectual disability.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18d13729a97d694834742f562d8ccf2e
https://doi.org/10.1016/j.pepo.2014.05.001
https://doi.org/10.1016/j.pepo.2014.05.001
Autor:
Magdalena, Zielińska, Joanna, Żółkowska, Amanda, Przybylska-Kruszewska, Dominika, Gładysz, Dorota, Korycińska-Chaaban, Maria, Nowacka, Kamil K, Hozyasz
Publikováno v:
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. 40(238)
Phenylketonuria is an inborn error of metabolism treated with a closely monitored low phenylalanine diet. Protein substitutes used for treatment are supplemented with vitamins and micronutrients.The aim of this study was to investigate plasma folic a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a09dba4c623e00e178ee058823df6156
https://pubmed.ncbi.nlm.nih.gov/27137821
https://pubmed.ncbi.nlm.nih.gov/27137821
Autor:
Miroslaw Bik-Multanowski, Anna Madetko-Talowska, Iwona Betka, Elzbieta Swieczka, Bozena Didycz, Karolina Orchel-Szastak, Kinga Bik-Multanowska, Ewa Starostecka, Joanna Jaglowska, Renata Mozrzymas, Joanna Zolkowska, Katarzyna Chyz, Dorota Korycinska-Chaaban
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 25, Iss , Pp 100640- (2020)
Purpose: Phenylketonuria (PKU) can be effectively treated with the use of a low-phenylalanine diet. However, some patients become overweight despite proper dietary treatment. We hypothesized that this phenomenon could be explained by the presence of
Externí odkaz:
https://doaj.org/article/25381154d73342a3ad185baa29970802